J.P. Morgan 2021

January 12, 2021June 30, 2021

by Elevation Oncology

Corporate Overview

Presenter: Shawn Leland, Founder and CEO
Date/Time: January 12, 2021 3:45 PM EST
Access: Free with registration. Recording will be available for 30 days following presentation (Expired 2/12/2021).

Other Related Resources

July 21, 2020February 22, 2021

Newsroom

Elevation Oncology Emerges from Stealth with $32.5M Series A to Develop Precision Medicines for Tumors Harboring Rare Genetic Driver Alterations Read More

September 30, 2020April 8, 2021

Press Releases

Elevation Oncology and US Oncology Research Announce Collaboration to Expand Genomic Testing of Solid Tumors and Local Site Activation in Support of the Phase 2 CRESTONE Study Read More

October 26, 2020March 3, 2021

Newsroom

Elevation Oncology Announces the Presentation of Preclinical Data on the Specific Inhibition of HER3 to Block NRG1 Fusion Signaling Read More

November 18, 2020March 3, 2021

Newsroom

Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer Read More

January 6, 2021March 3, 2021

Newsroom

Elevation Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference Read More

February 17, 2021June 30, 2021

Newsroom

LifeSci Partners Precision Oncology Day 2021 Read More